[PDF][PDF] Bupropion for Major Depressive Disorder or Persistent Depressive Disorder (Dysthymia)
E MacDonald, J Horton - Canadian Journal of Health …, 2021 - canjhealthtechnol.ca
• There is limited evidence supporting the cost-effectiveness of bupropion to augment
citalopram, and dominance of vortioxetine compared to bupropion, for major depressive …
citalopram, and dominance of vortioxetine compared to bupropion, for major depressive …
Bupropion for Major Depressive Disorder or Persistent Depressive Disorder (Dysthymia)[Internet]
E MacDonald, J Horton - 2021 - pubmed.ncbi.nlm.nih.gov
Major depressive disorder (MDD) has a high disease burden in Canada. It was estimated
that in 2012, the lifetime prevalence in Canada was 9.9%, and more than 1.5 million …
that in 2012, the lifetime prevalence in Canada was 9.9%, and more than 1.5 million …
[HTML][HTML] Bupropion for Major Depressive Disorder or Persistent Depressive Disorder (Dysthymia)
E MacDonald, J Horton - 2021 - europepmc.org
Major depressive disorder (MDD) has a high disease burden in Canada. It was estimated
that in 2012, the lifetime prevalence in Canada was 9.9%, and more than 1.5 million …
that in 2012, the lifetime prevalence in Canada was 9.9%, and more than 1.5 million …
[HTML][HTML] Bupropion for Major Depressive Disorder or Persistent Depressive Disorder (Dysthymia)
E MacDonald, J Horton - 2021 - ncbi.nlm.nih.gov
Direct and indirect evidence from 6 systematic reviews did not demonstrate a difference in
treatment response or remission rates, or functional outcomes, with bupropion as compared …
treatment response or remission rates, or functional outcomes, with bupropion as compared …
[PDF][PDF] Bupropion for Major Depressive Disorder or Persistent Depressive Disorder (Dysthymia)
E MacDonald, J Horton - Canadian Journal of Health …, 2021 - canjhealthtechnol.ca
• There is limited evidence supporting the cost-effectiveness of bupropion to augment
citalopram, and dominance of vortioxetine compared to bupropion, for major depressive …
citalopram, and dominance of vortioxetine compared to bupropion, for major depressive …
[HTML][HTML] Bupropion for Major Depressive Disorder or Persistent Depressive Disorder (Dysthymia)
E MacDonald, J Horton - 2021 - europepmc.org
Major depressive disorder (MDD) has a high disease burden in Canada. It was estimated
that in 2012, the lifetime prevalence in Canada was 9.9%, and more than 1.5 million …
that in 2012, the lifetime prevalence in Canada was 9.9%, and more than 1.5 million …